Showing results 1 to 2 of 2
Issue Date | Title | Journal Title |
---|---|---|
2024 | Durvalumab plus pazopanib combination in patients with advanced soft tissue sarcomas: a phase II trial | NATURE COMMUNICATIONS |
2022 | Phase II Clinical Trial of Eribulin-Gemcitabine Combination Therapy in Previously Treated Patients With Advanced Liposarcoma or Leiomyosarcoma | CLINICAL CANCER RESEARCH |